Join Our Next Live Briefing!

MC headshot small[1]
January 25, 2022 | Noon EDT | Episode 19

Strategies to Ensure Health Plan Coverage of Emerging Diagnostic Technologies

Maude Champagne, Pharmacologist and Healthcare Value Expert, Illumina 

Key Learnings:

  1. Clinical utility demonstration requires thoughtful evidence generation plan
  2. Emerging genomic diagnostic applications may not fit the traditional framework for clinical utility evaluation
  3. Additional strategies may be available to accelerate or enable coverage

Live Briefings

The Precision Medicine Institute's weekly live briefings feature experts covering today's most timely and critical precision medicine topics that hospital and health system executives need to understand.

Sponsored By

Stay Informed and Ahead of the Curve With Live Briefings That Matter

The Precision Medicine Institute's live briefings are free, weekly, 30-minute webinars that deliver useful, timely, and actionable information on precision medicine to CEOs, COOs, CFOs, CMOs, and other executives within hospitals, health systems, and multispecialty clinics. They feature thought leaders from across the field of precision medicine and are developed and moderated by Anne Tate and Deb Hewitt-Smith of our partner company, Talking Laboratories.

Subscribe to receive weekly invitations to our live briefings, including topic and expert speaker information and other important details.

Precision Medicine Institute live briefings - Anne Tate, MT (ASCP), SC, MBA, MHI

Anne Tate, MT (ASCP), SC, MBA, MHI, Anne has more than 25 years of experience in the laboratory management and healthcare consulting business. She is an experienced professional with a demonstrated history of managing laboratory information. Anne is fueled by her passion for laboratory informatics and software tools that enable the laboratory to achieve operational excellence.

Precision Medicine Institute live briefings - Deb Hewett-Smith

Deb Hewett-Smith is a strategic and innovative leader with proven success in driving results and empowering teams in the highly competitive healthcare IT and medical device industry sectors. With more than 25 years of experience, Deb is effective at building programs that connect the dots between customer value and business growth/retention.

Live Briefing Library

Look for previous episodes? Check out all our past episodes below!

Volume 2

Becky Winslow
Recorded January 4, 2022 | Episode 17

Pharmacogenomics Laboratory Stewardship: How Labs Can Leverage PharmDs for Laboratory Test Ordering, Retrieval, Interpretation, and Reimbursement

Becky Winslow, BS, PharmD, Founder of inGENEious RX, LLC Precision Medicine Consultants

Recorded January 18, 2022 | Episode 18

Digital Pathology - A Foundation for Precision Medicine

Lisa-Jean Clifford, COO and Chief Strategy Officer, Gestalt Diagnostics

Volume 1

Precision Medicine Institute Live Briefings Anthony Magliocco, MD
Recorded August 17, 2021 | Episode 1

Supporting Precision Oncology with Precision Pathology: The Promise and Challenges of a New Paradigm in Medicine

Anthony Magliocco, MD
Founder & CEO
Protean BioDiagnostics

Weinshilboum photo_08-16-21
Recorded August 24, 2021 | Episode 2

Pharmacogenomics to Pharmaco-omics

Richard Weinshilboum, MD
Professor of Pharmacology and Medicine and Dasburg Professor of Cancer Genomics Research
Mayo Clinic

Julie R.
Recorded August 31, 2021 | Episode 3

The Value of Precision Medicine: Shaping the Future of Healthcare

Julie Ramage
Director of Precision Medicine Quality Initiatives and Partnerships
AstraZeneca Pharmaceuticals

jason photo
Recorded September 9, 2021 | Episode 4

The Convergence of Pathology, AI and Drug Development and the Rise of Digital Precision Medicine

Jason Hipp, MD, PhD
Chair, Division of Computational Pathology & AI, Laboratory Medicine & Pathology, Mayo Clinic
Director, Digital Innovation, Mayo Clinic Labs

Sam Terese May 2021 Final
Recorded September 14, 2021 | Episode 5

Precision Medicine: Beyond Science - Why's and How's

Sam Terese
CEO & President
Alverno Laboratories

HowardMcLeod (1)
Recorded September 21, 2021 | Episode 6

Molecular Tumor Boards to Help Solve the Precision Medicine ‘Final Mile’ Problem

Howard McLeod, PharmD
Medical Director, Precision Medicine
Geriatric Oncology Consortium

Chandra-HR1 (1)
Recorded September 28, 2021 | Episode 7

Precision Oncology in Community Practice: An Evolving Landscape

Pranil Chandra, DO, FCAP, FASCP
Chief Medical Officer, Vice President, Genomic and Molecular Pathology, PathGroup
Advisor, Precision Medicine Institute

Recorded October 5, 2021 | Episode 8

So, You Want to Bill for NGS Testing? 5 Steps to Avoid Potential Pitfalls

Ann Lambrix
Vice President of RCM Consulting
Vachette Pathology

Emily-Johnson_Circle Speaker
Courtney Tito _Circle Speaker
Recorded October 12, 2021 | Episode 9

Regulatory and Reimbursement Considerations for Precision Medicine

Emily Johnson, Member, McDonald Hopkins
Courtney Tito, Member, McDonald Hopkins

Nash David 2019 headshot
Recorded October 26, 2021 | Episode 10

The Intersection of Population Health and Precision Medicine: Joining Forces to Improve Public Health Using Targeted Interventions

David Nash, MD, MBA
Founding Dean Emeritus
Dr. Raymond C. & Doris N. Grandon Professor of Health Policy at Jefferson College of Population Health

Recorded November 9, 2021 | Episode 11

The Impact of Artificial Intelligence in Precision Medicine

John Quackenbush, PhD, Professor of Computational Biology and Bioinformatics, Harvard
Chair of the Department of Biostatistics, Harvard T.H. Chan School of Public Health

EQ 2021a _Elissa
Recorded November 16, 2021 | Episode 12

Integrating Personalized Medicine into Healthcare: Advancing From Promise to Reality for More Patients

Elissa Quinn, Precision Medicine Advocacy, Policy & Partnerships at Blueprint Medicines

San Diego, CA, Aug. 21, 2017-- Dr. Stephen Kingsmore.  Photo by Earnie Grafton.
Recorded November 23, 2021 | Episode 13

Precision Medicine for Inpatient Children

Stephen F. Kingsmore, MD, DSc, President and CEO of Rady Children's Institute for Genomic Medicine

KA Headshot (1)
Recorded November 30, 2021 | Episode 14

Understanding the Clinical and Financial Impact of Unmanaged
Pharmacogenomic Risk

Kristine Ashcraft, Medical Affairs Director, Pharmacogenomics, Invitae

Recorded December 7, 2021 | Episode 15

Developing a Strategy for Next Generation Sequencing Reimbursement - Understanding the Barriers and Path to Consistent Revenue Growth

Robert Dumanois, Director of Reimbursement Strategy, Clinical Sequencing Division at Thermo Fisher Scientific

Jessie Conta Small
Recorded December 14, 2021 | Episode 16

Medical Necessity Apocalypse: Aligning patients, laboratories and payers to prevent financial toxicity and improve reimbursement

Michael Astion, MD, Medical Director and Jessie Conta, genetic counselor and Laboratory Stewardship Program Manager, Department of Laboratories, Seattle Children’s Hospital